I agree that this site is using cookies. You can find further informations here.
X
Fuseau, E.
28  results:
Search for persons X
?
1

Neutralization of EP217609, a new dual-action FIIa/FXa anti..:

Gueret, P. ; Combe, S. ; Krezel, C....
European Journal of Clinical Pharmacology.  73 (2016)  1 - p. 15-28 , 2016
Link: https://doi.org/10.1007/..
 
?
2

First in man study of EP217609, a new long-acting, neutrali..:

Gueret, Pierre ; Combe, S. ; Krezel, C....
European Journal of Clinical Pharmacology.  72 (2016)  9 - p. 1041-1050 , 2016
Link: https://doi.org/10.1007/..
 
?
3

EP42675, a synthetic parenteral dual-action anticoagulant: ..:

Gueret, P. ; Krezel, C. ; Fuseau, E....
Journal of Thrombosis and Haemostasis.  12 (2014)  1 - p. 24-33 , 2014
Link: https://doi.org/10.1111/..
 
?
4

Pharmacokinetics and safety of roledumab, a novel human rec..:

Yver, A. ; Homery, M.‐C. ; Fuseau, E....
Vox Sanguinis.  103 (2012)  3 - p. 213-222 , 2012
Link: https://doi.org/10.1111/..
 
?
5

Supporting the recommended paediatric dosing regimen for ru..:

Marchand, M. ; Fuseau, E. ; Critchley, D. J.
Journal of Pharmacokinetics and Pharmacodynamics.  37 (2010)  1 - p. 99-118 , 2010
Link: https://doi.org/10.1007/..
 
?
6

Cns Effects of Sumatriptan and Rizatriptan in Healthy Femal..:

van der Post, J ; Schram, MT ; Schoemaker, RC...
Cephalalgia.  22 (2002)  4 - p. 271-281 , 2002
Link: https://doi.org/10.1046/..
 
?
7

Meta-analysis of the exposure/efficacy relationship for sum..:

PETRICOUL, O ; FUSEAU, E
Clinical Pharmacology & Therapeutics.  65 (1999)  2 - p. 166-166 , 1999
Link: https://doi.org/10.1016/..
 
?
8

Comparative clinical pharmacokinetics of single doses of su..:

Duquesnoy, C ; Mamet, J.P ; Sumner, D.
European Journal of Pharmaceutical Sciences.  6 (1998)  2 - p. 99-104 , 1998
Link: https://doi.org/10.1016/..
 
?
9

5-21-24 A study to investigate the central effects of narat..:

Williams, P. ; Clare, C. ; Crisp, A....
Journal of the Neurological Sciences.  150 (1997)  - p. S306 , 1997
Link: https://doi.org/10.1016/..
 
?
10

1-21-10 Factors affecting oral naratriptan pharmacokinetics..:

Fuseau, E. ; Webster, C. ; Aspharnejad, M..
Journal of the Neurological Sciences.  150 (1997)  - p. S33 , 1997
Link: https://doi.org/10.1016/..
 
?
11

3-21-02 Naratriptan oral pharmacokinetic-pharmacodynamic mo..:

Fuseau, E. ; Webster, C. ; Asgharnejad, M...
Journal of the Neurological Sciences.  150 (1997)  - p. S167 , 1997
Link: https://doi.org/10.1016/..
 
?
12

5-21-06 A pharmacokinetic-pharmacodynamic meta-analysis of ..:

Grevel, J. ; Fuseau, E. ; Kempsford, R.D.
Journal of the Neurological Sciences.  150 (1997)  - p. S303-S304 , 1997
Link: https://doi.org/10.1016/..
 
?
13

1-21-09 Naratriptan oral pharmacokinetics in migraine subje..:

Fuseau, E. ; Webster, C. ; Asgharnejad, M..
Journal of the Neurological Sciences.  150 (1997)  - p. S33 , 1997
Link: https://doi.org/10.1016/..
 
?
14

3-21-01 The pharmacokinetics of oral naratriptan in subject..:

Fuseau, E. ; Kempsford, R.D. ; Moss, J....
Journal of the Neurological Sciences.  150 (1997)  - p. S167 , 1997
Link: https://doi.org/10.1016/..
 
?
15

Safety, Tolerability, and Pharmacokinetics of Sumatriptan i..:

Moore, KHP ; Hussey, EK ; Shaw, S...
Cephalalgia.  17 (1997)  4 - p. 541-550 , 1997
Link: https://doi.org/10.1046/..
 
1-15